glp-1 fill finish cdmo Drug Manufacturing: Expansion & Tech Transfer CDMO/CMO Outlook: Fill-Finish: A Capacity
Description
The study also included people who did not plan to take a GLP-1
Baur, a renowned expert in NAD (nicotinamide adenine dinucleotide) research
Accordingly, Ying Lee, a fellow in the Drucker laboratory, generated a transgenic mouse expressing the SV40 T antigen cDNA under the control of the proglucagon gene promoter
Diabetologia 62:316
